Pasithea Therapeutics Corp (KTTA)
6.40
-0.15
(-2.29%)
USD |
NASDAQ |
May 24, 16:00
6.41
+0.01
(+0.16%)
After-Hours: 20:00
Pasithea Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2021 | -14.69% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-14.69%
Minimum
Dec 2021
-14.69%
Maximum
Dec 2021
-14.69%
Average
-14.69%
Median
Dec 2021
Gross Profit Margin (Quarterly) Benchmarks
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 80.00% |
IGC Pharma Inc | 65.20% |
NovaBay Pharmaceuticals Inc | 68.19% |
Protalix BioTherapeutics Inc | 30.58% |